Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atlanta Braves Holdings (BATRA) Gains from Investment Securities (2022 - 2025)

Historic Gains from Investment Securities for Atlanta Braves Holdings (BATRA) over the last 4 years, with Q3 2025 value amounting to $6.3 million.

  • Atlanta Braves Holdings' Gains from Investment Securities fell 609.17% to $6.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.4 million, marking a year-over-year decrease of 972.1%. This contributed to the annual value of $21.6 million for FY2024, which is 377.73% down from last year.
  • Latest data reveals that Atlanta Braves Holdings reported Gains from Investment Securities of $6.3 million as of Q3 2025, which was down 609.17% from $3.1 million recorded in Q2 2025.
  • Atlanta Braves Holdings' Gains from Investment Securities' 5-year high stood at $10.1 million during Q4 2023, with a 5-year trough of -$42.4 million in Q4 2022.
  • Its 4-year average for Gains from Investment Securities is $1.6 million, with a median of $6.1 million in 2023.
  • As far as peak fluctuations go, Atlanta Braves Holdings' Gains from Investment Securities soared by 32012.58% in 2024, and later crashed by 3978.2% in 2025.
  • Quarter analysis of 4 years shows Atlanta Braves Holdings' Gains from Investment Securities stood at -$42.4 million in 2022, then skyrocketed by 123.85% to $10.1 million in 2023, then dropped by 10.4% to $9.0 million in 2024, then tumbled by 30.33% to $6.3 million in 2025.
  • Its Gains from Investment Securities was $6.3 million in Q3 2025, compared to $3.1 million in Q2 2025 and $2.0 million in Q1 2025.